Live from the NIH registry
Studies recruiting near Hickory right now
Top 25 of 96 recruiting studies, sorted by proximity — each links to its official registry page
Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
Depressive Disorder, Major
Phase 3
Interventional 752 participants sought
IMA Clinical Research PC 3 — Hickory, North Carolina (1.2 mi)
· Sponsor: Janssen Research & Development, LLC
Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD
COPD, Chronic Obstructive Pulmonary Disease
N/A
Interventional 200 participants sought
Wake Forest School of Medicine — Salem, North Carolina (21.2 mi)
· Sponsor: Nuvaira, Inc.
A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis
Plaque Psoriasis
Phase 3
Interventional 366 participants sought
Local Institution - 0234 — Hickory, North Carolina (1.2 mi)
· Sponsor: Bristol-Myers Squibb
A Double-blind, Randomized Controlled Trial to Investigate the Efficacy, Safety, and Pharmacokinetics of Pegloticase Administration Via Subcutaneous and Intravenous Routes Both With Methotrexate in Participants With Uncontrolled Gout
Uncontrolled Gout
Phase 3
Interventional 270 participants sought
Research Carolina Elite — Denver, North Carolina (21.9 mi)
· Sponsor: Amgen
A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
Weight Management
Phase 3
Interventional 4,500 participants sought
Research Site — Statesville, North Carolina (24.6 mi)
· Sponsor: AstraZeneca
Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer
Locally Advanced Pancreatic Adenocarcinoma, Stage III Pancreatic Cancer AJCC v8
Phase 1, Phase 2
Interventional 92 participants sought
Wake Forest Baptist Health - Wilkes Medical Center — Wilkesboro, North Carolina (29.4 mi)
· Sponsor: National Cancer Institute (NCI)
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma
Phase 3
Interventional 382 participants sought
Wake Forest Baptist Health - Wilkes Medical Center — Wilkesboro, North Carolina (29.4 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Novant Health Cancer Institute - Statesville — Statesville, North Carolina (24.6 mi)
· Sponsor: SWOG Cancer Research Network
A Study of XB628 Alone and in Combination With Zanzalintinib in Participants With Recurrent Advanced or Metastatic Solid Tumors
Solid Tumor, Advanced Solid Tumor
Phase 1
Interventional 303 participants sought
Exelixis Clinical Site #1 — Hickory, North Carolina (1.2 mi)
· Sponsor: Exelixis
A Study to Learn About the Study Medicine Called Zavegepant (PF-07930207) in Children With a History of Migraine
Acute Treatment of Migraine
Phase 1
Interventional 16 participants sought
Accellacare - Piedmont — Statesville, North Carolina (24.6 mi)
· Sponsor: Pfizer
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
High Risk Cardiovascular Disease, Hypertension
Phase 3
Interventional 11,000 participants sought
Clinical Trial Site — Statesville, North Carolina (24.6 mi)
· Sponsor: Alnylam Pharmaceuticals
A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer
Cervical Cancer
N/A
Interventional 840 participants sought
Novant Health Cancer Institute — Statesville, North Carolina (24.6 mi)
· Sponsor: GOG Foundation
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Stage I Breast Cancer
Phase 3
Interventional 1,670 participants sought
Novant Health Cancer Institute - Statesville — Statesville, North Carolina (24.6 mi)
· Sponsor: NRG Oncology
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Diabetes Mellitus, Type 2, Hypertension
Phase 3
Interventional 11,800 participants sought
IMA Clinical Research Lenoir — Lenoir, North Carolina (17.0 mi)
· Sponsor: Boehringer Ingelheim
A Study to Investigate IGT-303 in Healthy Volunteers and Participants With Chronic Kidney Disease
Healthy Volunteers, Chronic Kidney Disease
Phase 1, Phase 2
Interventional 94 participants sought
Piedmont HealthCare — Statesville, North Carolina (24.6 mi)
· Sponsor: Ingenia Therapeutics INC
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
COPD (Chronic Obstructive Pulmonary Disease)
Phase 3
Interventional 5,250 participants sought
Research Site — Statesville, North Carolina (24.6 mi)
· Sponsor: AstraZeneca
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
Metastatic Breast Cancer
Phase 3
Interventional 500 participants sought
Levine Cancer Institute — Lincolnton, North Carolina (18.9 mi)
· Sponsor: American Society of Clinical Oncology
Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials
Breast Cancer, NOS, CNS Primary Tumor, NOS
N/A
Interventional 400 participants sought
CaroMont Health - Lincoln Cancer Center — Lincolnton, North Carolina (18.9 mi)
· Sponsor: Eastern Cooperative Oncology Group
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
Refractory Rheumatoid Arthritis (RA), Idiopathic Inflammatory Myopathies (IIMs)
Phase 2
Interventional 90 participants sought
Artiva Investigational Site Statesville — Statesville, North Carolina (24.6 mi)
· Sponsor: Artiva Biotherapeutics, Inc.
A Study of TAK-360 in Adults With Narcolepsy Without Cataplexy (NT2)
Narcolepsy Type 2
Phase 2
Interventional 88 participants sought
Takeda Site 8 — Denver, North Carolina (21.9 mi)
· Sponsor: Takeda
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Atherosclerotic Cardiovascular Disease, Overweight
Phase 3
Interventional 12,800 participants sought
Burke Primary Care Family Practice — Morganton, North Carolina (20.3 mi)
· Sponsor: Amgen
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
Chronic Obstructive Pulmonary Disease
Phase 3
Interventional 942 participants sought
Advanced Respiratory and Sleep Medicine - Hickory- Site Number : 8400013 — Hickory, North Carolina (1.2 mi)
· Sponsor: Sanofi
Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial
Lung Non-Small Cell Carcinoma
Phase 3
Interventional 336 participants sought
Atrium Health Lincoln/LCI-Lincolnton — Lincolnton, North Carolina (18.9 mi)
· Sponsor: National Cancer Institute (NCI)
A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
Obesity, Type 2 Diabetes
Phase 3
Interventional 2,500 participants sought
Piedmont Healthcare/Research — Statesville, North Carolina (24.6 mi)
· Sponsor: Novo Nordisk A/S
An Extension Study to Assess Long-Term Safety and Tolerability of Adjunctive KarXT in Subjects With Inadequately Controlled Symptoms of Schizophrenia
Schizophrenia
Phase 3
Interventional 280 participants sought
Local Institution - 176 — Hickory, North Carolina (1.2 mi)
· Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company